Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago
60 mg+400 mg
Strip (6): ৳6,000.00 Box (1 × 6 = 6): ৳6,000.00
৳1,000.00 per tablet

Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.

All price changes →
From ৳1,000.00 per tablet
Available as: 60 mg+400 mg · 1 x 6

More from Darvoni

Other strengths and forms by Beacon Pharmaceuticals PLC

Indications & Uses

Sofosbuvir goes straight for the Hepatitis C virus and stops it making copies of itself in the liver. It does this by attaching to the virus's genetic information, called RNA, which blocks the virus from multiplying. Daclatasvir works alongside it as a direct-acting antiviral agent (DAA) against the Hepatitis C virus.

Pharmacology

Sofosbuvir blocks the hepatitis C virus (HCV) enzyme NS5B RNA-dependent RNA polymerase, which the virus needs to replicate. It is a nucleotide prodrug, so it is changed inside the cell into its active form, a uridine analog triphosphate called GS-461203. The NS5B polymerase takes GS-461203 into the HCV RNA, and there it acts as a chain terminator. In a biochemical assay, GS-461203 inhibited the polymerase activity of recombinant NS5B from HCV genotype 1b, 2a, 3a and 4a, with a 50% inhibitory concentration (IC50) value ranging from 0.7 to 2.6 micrometer. GS-461203, the active metabolite of sofosbuvir, does not inhibit human DNA or RNA polymerases, and it does not inhibit mitochondrial RNA polymerase either.

Daclatasvir stops HCV viral RNA replication and protein translation by directly inhibiting the HCV protein NS5A. NS5A is critical for HCV viral transcription and translation.

Dosage Reference

Reference Information Only

Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.

Detailed dosing reference is not available yet. Please follow your prescription and consult your pharmacist.

Side Effects

Side-effect information is not available for this brand yet.

Common questions about Darvoni 60 mg+400 mg

What is Darvoni 60 mg+400 mg Tablet?

Darvoni 60 mg+400 mg Tablet is a medicine that contains Daclatasvir + Sofosbuvir. It is made by Beacon Pharmaceuticals PLC. It belongs to the Hepatic viral infections (Hepatitis C) group of medicines.

What is Darvoni used for?

Sofosbuvir goes straight for the Hepatitis C virus and stops it making copies of itself in the liver. It does this by attaching to the virus's genetic information, called RNA, which blocks the virus from multiplying.

Is there a cheaper medicine with the same ingredient?

Darvoni is already among the lowest-priced brands of Daclatasvir + Sofosbuvir at this strength.

Do I need a prescription for Darvoni?

Darvoni is a prescription (Rx) medicine. Take it as your doctor advises.

Last updated: 18 Aug 2026